Robert Liptak, 10% Owner at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 1,732,678 shares at $4.80 ($7.9M) on 2010-11-05, disclosed to the SEC on 2010-11-05.
Open-market sale of $7.9M AVNR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.52 | 1,400,106 | $6.3M | 79.9% |
| 2 | $4.80 | 332,572 | $1.6M | 20.1% |
| Total | $4.57 avg | 1,732,678 | $7.9M | 100% |
| Filing → |
| OXFD | SELL | 2015-03-24 | $774K | — | Filing → |
| AERI | SELL | 2015-01-06 | $729K | — | Filing → |
| AERI | SELL | 2014-12-30 | $2.4M | — | Filing → |